Emerging Trends in the Clinical Management of Cardiovascular Disease in Postmenopausal Women
Paper Symposium
Activity Date: October 2002  — Activity Info: Volume 2, (20)
Goals & Objectives | Faculty | Introduction | Full Activity Content | CME Test & Evaluation (CME Expired) | Order Copy of Activity



    Roger S. Blumenthal, MD, FACC
    Director, Johns Hopkins Ciccarone Center for the Prevention of Heart Disease
    Associate Professor of Medicine
    Department of Cardiology
    Johns Hopkins University School of Medicine
    Baltimore, Maryland
    • Dr Blumenthal reports receiving grants and/or research support from Pfizer, Kos, Merck, Novartis, and Wyeth Ayerst; and has received honoraria from Pfizer, Kos, Merck, Novartis, and Wyeth Ayerst.


    Nanette K. Wenger, MD
    Chief of Cardiology, Grady Memorial Hospital
    Clinical Professor of Medicine
    Division of Cardiology
    Emory University School of Medicine
    Atlanta, Georgia
    • Dr Wenger reports receiving grant/research support from Bristol-Myers Squibb, Eli Lilly & Co., Solvay Pharmaceuticals, Wyeth Ayerst; consulting for Bristol-Myers Squibb; CV Therapeutics Inc.; Dupont Pharmaceuticals; Eli Lilly; Pfizer; Merck; SmithKlineBeecham; Women First Healthcare, Inc; and participating on the Speakers Bureau for Aventis Pharmaceuticals, Bristol-Myers Squibb, Dupont Pharma, Eli Lilly & Co., Pfizer, Inc., Merck, and Wyeth Ayerst.

Advanced Studies in Medicine provides disclosure information from contributing authors, lead presenters, and participating faculty. Advanced Studies in Medicine does not provide disclosure information from authors of abstracts and poster presentations. The reader shall be advised that these contributors may or may not maintain financial relationships with pharmaceutical companies.

Home | Contact Us | View Account | Need Help?